Autonomix Medical, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.7M | $-2.7M | $-3.3M | $-7.5M | $-3.3M | $-11.4M | $-2.7M | $-2.8M |
| Depreciation & Amortization | $3.0K | $3.0K | $4.0K | $2.0K | $3.0K | $183.0K | $47.0K | $45.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.0K | $1.0K | $2.0K | $138.0K | $388.0K | $1.6M | $418.0K | $445.0K |
| Net Cash from Operating Activities | $-3.5M | $-2.9M | $-3.0M | $-3.8M | $-2.6M | $-8.3M | $-2.3M | $-1.6M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $3.0K | $7.0K | $0 | $0 | $14.0K | $5.0K | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-3.0K | $-7.0K | $0 | $0 | $-14.0K | $-5.0K | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $-35.0K | $5.4M | $2.7M | $2.1M | $8.8M | $9.0M | $0 |
| Net Change in Cash | $-3.5M | $-2.9M | $2.5M | $-1.1M | $-547.0K | $528.0K | $6.7M | $-1.6M |
| Free Cash Flow | — | $-2.9M | $-3.0M | $-3.8M | $-2.6M | $-8.3M | $-2.3M | $-1.6M |